Carla Territo
Retina Specialist · Florissant, MONPI 1851403190
Payments from drug & device makers
Across 228 payments — averaging $90.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$9K
- Eyepoint US, Inc.$2K
- Genentech USA, Inc.$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Apellis Pharmaceuticals, Inc.$794
- Bausch & Lomb, A Division Of Bausch Health US, LLC$652
- plus $5K from 20 others
What the payments were for
- Consulting fees$1,8509%
- Food & beverage$9,48046%
- Ownership interest$3,64718%
- Other$5,54327%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 10 | $9,190 |
| Eyepoint US, Inc. | 4 | $2,116 |
| Genentech USA, Inc. | 48 | $1,504 |
| Regeneron Healthcare Solutions, Inc. | 35 | $1,058 |
| Apellis Pharmaceuticals, Inc. | 9 | $794 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 15 | $652 |
| Bausch & Lomb Americas Inc. | 8 | $582 |
| Alimera Sciences, Inc. | 19 | $579 |
| AbbVie(2 entities) | 19 | $538 |
| Novartis | 14 | $519 |
| Astellas Pharma US Inc | 10 | $451 |
| Biotissue Holdings Inc. | 8 | $391 |
| ANI Pharmaceuticals, Inc. | 3 | $352 |
| Alcon | 3 | $278 |
| Eyevance Pharmaceuticals LLC | 2 | $217 |
| Regeneron | 2 | $215 |
| Mallinckrodt Hospital Products Inc. | 4 | $209 |
| Harrow Eye, LLC | 3 | $203 |
| Sight Sciences, Inc. | 1 | $142 |
| Glaukos Corporation | 1 | $129 |
| Kala Pharmaceuticals, Inc. | 1 | $124 |
| Ocular Therapeutix, Inc. | 1 | $103 |
| Mallinckrodt Enterprises LLC | 5 | $86 |
| The Cameron-ehlen Group, Inc. | 1 | $43 |
| Biogen | 1 | $27 |
| Genentech, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYP-1901$1,975
- Syfovre$632
- VABYSMO$495
- enVista MX60 IOL$356
- STELLARIS$341
- PURIFIED CORTROPHIN GEL$325
- Prokera$244
- AmnioGraft$244
- EYLEA HD$240
- Izervay$238
- Tobradex ST$200
- TRIESENCE$150
- Iluvien$143
- OMNI(R) SURGICAL SYSTEM (US)$142
- Hydrus Microstent$138
- EYLEA$125
- OZURDEX$125
- MIEBO$125
- ACTHAR$125
- INVELTYS$124
How this compares
$20,520 in reported general payments places this provider in the 70th percentile of 45 retina specialist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 98 | $3,864 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 25 | $3,406 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 46 | $2,024 |
| Ketorolac Tromethamine | 91 | $1,572 |
| Dorzolamide Hcl | 15 | $297 |
| Latanoprost | 52 | $290 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 11 | $185 |
| Diclofenac Sodium | 12 | $140 |
| Timolol Maleate | 16 | $138 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Florissant
- David GlaserFlorissant$109K
- Blonie DudneyFlorissant$10K
- Clayton ScanlonFlorissant$3K
- Kevin BlinderBrentwood$2.2M
- Alia DurraniBrentwood$1.3M
- Aaron LeeSaint Louis$780K
- Sabin DangBrentwood$486K
- Michael CassellKansas City$389K
- Athanasios PapakostasBrentwood$262K
- Bradley SmithBrentwood$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.